PL3125867T3 - Hiperosmolarna kompozycja kwasu hialuronowego - Google Patents
Hiperosmolarna kompozycja kwasu hialuronowegoInfo
- Publication number
- PL3125867T3 PL3125867T3 PL15723135T PL15723135T PL3125867T3 PL 3125867 T3 PL3125867 T3 PL 3125867T3 PL 15723135 T PL15723135 T PL 15723135T PL 15723135 T PL15723135 T PL 15723135T PL 3125867 T3 PL3125867 T3 PL 3125867T3
- Authority
- PL
- Poland
- Prior art keywords
- hyaluronic acid
- hyperosmolar
- composition
- hyperosmolar composition
- hyaluronic
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 230000002727 hyperosmolar Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1452929A FR3019465B1 (fr) | 2014-04-02 | 2014-04-02 | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen |
| PCT/EP2015/057186 WO2015150459A1 (fr) | 2014-04-02 | 2015-04-01 | Composition hyperosmolaire d'acide hyaluronique |
| EP15723135.8A EP3125867B1 (fr) | 2014-04-02 | 2015-04-01 | Composition hyperosmolaire d'acide hyaluronique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3125867T3 true PL3125867T3 (pl) | 2022-03-21 |
Family
ID=51063623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15723135T PL3125867T3 (pl) | 2014-04-02 | 2015-04-01 | Hiperosmolarna kompozycja kwasu hialuronowego |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20170128484A1 (pl) |
| EP (2) | EP3125867B1 (pl) |
| JP (1) | JP6770436B2 (pl) |
| CA (1) | CA2960884C (pl) |
| DK (1) | DK3125867T3 (pl) |
| ES (1) | ES2899759T3 (pl) |
| FR (1) | FR3019465B1 (pl) |
| MX (1) | MX376191B (pl) |
| PL (1) | PL3125867T3 (pl) |
| PT (1) | PT3125867T (pl) |
| WO (1) | WO2015150459A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3297733A1 (fr) | 2015-05-21 | 2018-03-28 | Ophtalmis Monaco | Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur |
| WO2016185000A1 (fr) | 2015-05-21 | 2016-11-24 | Ophtalmis Monaco | Composition ophtalmique comprenant de l'acide lipoique et un polymere muco-mimetique |
| IT201800010796A1 (it) | 2018-12-04 | 2020-06-04 | Vincenzo Orfeo | Unguenti oftalmici ipertonici stabili contenenti una fase idrofila satura di sodio cloruro |
| EP3970751B1 (en) | 2020-09-22 | 2023-08-23 | OmniVision GmbH | Ophthalmic composition for the treatment of corneal edema |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989000044A1 (en) * | 1987-07-07 | 1989-01-12 | Santen Pharmaceutical Co., Ltd. | Artificial lacrima |
| DE102005055275A1 (de) | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| EA017752B1 (ru) | 2006-12-11 | 2013-02-28 | Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. | Применение l-карнитина для получения лекарственного средства в форме глазных капель для лечения отека роговицы |
| EP2437743A4 (en) | 2009-06-05 | 2012-11-28 | Aciex Therapeutics Inc | OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE |
| US8283463B2 (en) | 2010-02-09 | 2012-10-09 | Bausch & Lomb Incorporated | Sterile hyaluronic acid solutions |
| FR2963240B1 (fr) * | 2010-07-28 | 2013-03-15 | Horus Pharma | Composition a usage topique sans conservateur comprenant de l'acide hyaluronique |
| IT1401494B1 (it) | 2010-07-30 | 2013-07-26 | Eupharma Srl | Formulazioni inalatorie in forma di soluzioni o polveri secche, per la rimozione delle secrezioni mucose dall'apparato respiratorio |
| ITRM20110105A1 (it) * | 2011-03-03 | 2012-09-04 | Sooft Italia Spa | Composizione ed uso di collirio antiedemigeno a base di acido lattobionico |
| US9636355B2 (en) * | 2011-09-22 | 2017-05-02 | Theo Holdings, Llc | Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion |
| CA2905988C (en) | 2013-03-14 | 2021-04-06 | Church & Dwight Co., Inc. | Aqueous lubricant composition comprising hyaluronic acid |
-
2014
- 2014-04-02 FR FR1452929A patent/FR3019465B1/fr active Active
-
2015
- 2015-04-01 PL PL15723135T patent/PL3125867T3/pl unknown
- 2015-04-01 PT PT157231358T patent/PT3125867T/pt unknown
- 2015-04-01 US US15/301,045 patent/US20170128484A1/en not_active Abandoned
- 2015-04-01 MX MX2016012758A patent/MX376191B/es active IP Right Grant
- 2015-04-01 CA CA2960884A patent/CA2960884C/fr active Active
- 2015-04-01 JP JP2016560353A patent/JP6770436B2/ja active Active
- 2015-04-01 ES ES15723135T patent/ES2899759T3/es active Active
- 2015-04-01 EP EP15723135.8A patent/EP3125867B1/fr active Active
- 2015-04-01 WO PCT/EP2015/057186 patent/WO2015150459A1/fr active Application Filing
- 2015-04-01 EP EP21196652.8A patent/EP3998062A1/fr not_active Withdrawn
- 2015-04-01 DK DK15723135.8T patent/DK3125867T3/da active
-
2019
- 2019-06-13 US US16/439,804 patent/US11110116B2/en active Active
-
2021
- 2021-09-07 US US17/467,918 patent/US11642367B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015150459A1 (fr) | 2015-10-08 |
| US20210401872A1 (en) | 2021-12-30 |
| DK3125867T3 (da) | 2021-12-06 |
| EP3998062A1 (fr) | 2022-05-18 |
| MX376191B (es) | 2025-03-07 |
| EP3125867A1 (fr) | 2017-02-08 |
| PT3125867T (pt) | 2021-12-02 |
| EP3125867B1 (fr) | 2021-09-15 |
| CA2960884C (fr) | 2023-08-15 |
| JP2017509668A (ja) | 2017-04-06 |
| CA2960884A1 (fr) | 2015-10-08 |
| FR3019465B1 (fr) | 2017-06-23 |
| US20190307789A1 (en) | 2019-10-10 |
| US20170128484A1 (en) | 2017-05-11 |
| US11110116B2 (en) | 2021-09-07 |
| JP6770436B2 (ja) | 2020-10-14 |
| MX2016012758A (es) | 2017-04-27 |
| ES2899759T3 (es) | 2022-03-14 |
| US11642367B2 (en) | 2023-05-09 |
| FR3019465A1 (fr) | 2015-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258062A1 (zh) | 給予惡拉戈利的方法 | |
| PL3640486T3 (pl) | Mebel | |
| GB2541833B (en) | Improvements to implant surfaces | |
| PT3215132T (pt) | Amantadina para melhorar a marcha em esclerose múltipla | |
| SG11201704737SA (en) | Novel aqueous composition | |
| SG11201704740WA (en) | Aqueous composition | |
| PL3118260T3 (pl) | Kompozycja poli(kwasu mlekowego) | |
| GB201408167D0 (en) | Compositions | |
| IL251479A0 (en) | components | |
| PT3125867T (pt) | Composição hiperosmolar de ácido hialurónico | |
| HK1231403A1 (zh) | 抑制β 表達的核酸 | |
| SG11201702202UA (en) | Aqueous composition | |
| GB201420306D0 (en) | Compositions | |
| GB201418900D0 (en) | Production of an aromatic discarboxylic acid | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| TWM490537U (en) | Structure of stand | |
| EP3115378A4 (en) | Hyaluronic acid modified by sphingosine-1-phosphoric acid | |
| GB2522473B (en) | Improvements to windposts | |
| GB201408233D0 (en) | Use of polyanionic composition | |
| GB201412359D0 (en) | Composition of objects | |
| GB201412089D0 (en) | Composition of objects | |
| GB2520781B (en) | Improvements to hydro-turbines | |
| GB201418410D0 (en) | use of compositions of matter | |
| HUE036695T2 (hu) | Ubidekarenon készítmény | |
| GB201414314D0 (en) | Manufacture of graphene |